Survival improved significantly for persons younger than 60 years with diffuse large B-cell lymphoma when they underwent intensified chemotherapy compared with the standard regimen.
People with advanced non-small cell lung cancer tumors expressing high levels of epidermal growth factor receptor are more likely to benefit when cetuximab (Erbitux) is used with chemotherapy.
A regimen using minimal-intensity radiation therapy before bone marrow or stem cell transplantation may work for older patients who cannot tolerate stronger pretransplant treatment.
A computer-based training program improved oncologists’ responses to negative emotions expressed by patients with advanced cancer.
Postmenopausal women who have gained weight in adulthood are at greater risk of developing endometrial cancer than are women who maintain a stable weight, indicates a recent study.
Recent study results suggest that a targeted immunotherapy based on a poxvirus may make chemotherapy for advanced non-small cell lung cancer more effective and slow disease progression.
Unlike men with prostate cancer, those with colorectal cancer are not routinely offered information and treatment for erectile dysfunction (ED), charge the authors of a new study.
An Internet-based, multimedia informed-consent tool is on track to increase clinical-trial enrollment at the University of Pennsylvania.
Researchers have determined that the standard radiation dose of 60 Gy should remain in place for persons with stage III non-small cell lung cancer (NSCLC).
Oxaliplatin, which has become the standard of care in advanced colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.
